Uwe Salzer
Direktor/Vorstandsmitglied bei Esteve Pharmaceuticals Ltd.
Profil
Uwe Salzer is currently a Director at Esteve Pharmaceuticals Ltd.
He was previously a Director at Abbey Pharma Ltd.
Aktive Positionen von Uwe Salzer
| Unternehmen | Position | Beginn |
|---|---|---|
Esteve Pharmaceuticals Ltd.
 Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Uwe Salzer
| Unternehmen | Position | Ende |
|---|---|---|
Abbey Pharma Ltd.
 Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Direktor/Vorstandsmitglied | 31.08.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Abbey Pharma Ltd.
Abbey Pharma Ltd. Pharmaceuticals: MajorHealth Technology Abbey Pharma Ltd. manufactures and distributes pharmaceutical products. Its products address therapeutic areas covering ophthalmology, oncology, pain, gastrointestinal, and dermatology. The company was founded in 2009 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Esteve Pharmaceuticals Ltd.
Esteve Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Esteve Pharmaceuticals Ltd. manufactures pharmaceutical products. It specializes in lactulose sachets, terra cortril, carbocisteine sachets, triamcinolone hexacetonide, naltrexone implants and generics. The company was founded in June 27, 1997 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
